🔎 Trials Near Me

Home › Marginal Zone Lymphoma › Utah › Salt Lake City

Marginal Zone Lymphoma clinical trials in Salt Lake City, UT

6 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

RecruitingPhase 1
  • Intermountain Healthcare, Salt Lake City
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07101328

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

RecruitingPhase 1
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT04830137

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

RecruitingPhase 1
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT04775745

Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)

RecruitingPhase 2
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT06390956

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

RecruitingPhase 1/2
  • University of Utah, Salt Lake City
Ages 18 and older · All sexes · Updated Nov 14, 2025 · NCT05643742

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Salt Lake City
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Marginal Zone Lymphoma trials in other cities

Other studies in Salt Lake City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.